Purple Dogshit defies its provocative moniker by presenting as a useful medical cultivar. It is an indica-dominant hybrid with lineage traced to Dogshit and Purple Urkle, and while the precise genetic balance is not fully mapped, observers describe it as predominantly indica with a touch of uplift from its sativa heritage. THC lands around 19 percent, with CBD present in negligible amounts, situating this rare strain among those sought for relief rather than recreation. Its rarity is underscored by limited documentation beyond its medical niche, especially outside Washington State.
Visually striking, the buds show a dark purple core interlaced with flecks of brown, green and gold, a characteristic brought forth by its Purple ancestry. The aroma carries a grape-like sweetness tempered by a floral bouquet, though whispers of its stinky parent still linger on the nose. The flavor mirrors the grape notes, offering a smooth, fruity profile that betrays the potency beneath.
The effects arrive quickly, delivering a soothing body buzz that promotes deep relaxation and bedrock calm. Users report relief from anxiety, stress, and tension, with additional potential benefits for pain and insomnia. The duration sits around an hour and a half, making it a useful option for focused relief at the end of the day. In practical terms, Purple Dogshit is available in the medical market in Washington State but remains rare elsewhere, and common adverse effects include dry mouth and red eyes, as with many cannabis strains.